Development and Validation of the VA Lung Cancer Mortality (VALCAN-M) Score for 90-day Mortality Following Surgical Treatment of Clinical Stage I Lung Cancer.
Brendan T HeidenDaniel B EatonWhitney S BrandtSu-Hsin ChangYan YanMartin W SchoenMayank R PatelDaniel KreiselRuben G NavaBryan F MeyersBenjamin D KozowerVarun PuriPublished in: Annals of surgery (2022)
The VALCAN-M score uses readily available treatment-related variables to reliably predict 90-day operative mortality. This score can aid surgeons and other providers in objectively discussing operative risk among high-risk patients with clinical stage I NSCLC considering surgery versus other definitive therapies.